Article and Video CATEGORIES

Cancer Journey

Search By

2020 PEA Program - Medhavi Gupta MD, Breast Cancer Series Antibody-Drug Conjugate Treatment Options
2020 PEA Program Breast Cancer Series - Gupta - Antibody-Drug Conjugate Treatment Options
Author
Medhavi Gupta, MD
Image
Dr. Medhavi Gupta, one of the participants in this past year's GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer.

For this series, Dr. Gupta discusses Metastatic Triple-Negative Breast Cancer with Dr. Aditya Bardai.

Dr. Bardai is Assistant Professor of Medicine at Harvard Medical School and Attending Physician in Medical Oncology at Massachusetts General Hospital.

 

In this video, Drs. Gupta and Bardai discuss Antibody-Drug Conjugate Treatment Options

#breastcancer #Metastases #triplenegative #cancerGRACE #genentech #lilly

To join the conversation, visit https://cancergrace.org/forum.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora